Skip to main content

Accuray Incorporated

corporate_fare Company Profile

Accuray Incorporated

ARAY·NASDAQ·Industrial Applications And Services·CIK 0001138723

Accuray Incorporated is a radiation therapy company that develops, manufactures, sells, and supports solutions for treatment delivery, planning, imaging, and data management. These solutions are designed to assist clinical teams in providing precise radiation treatments for a wide variety of clinical cases. The company's product portfolio features the CyberKnife robotic platform and a distinct helical portfolio, which includes the Accuray Stellar, Radixact, Accuray Helix, and Tomo C Systems, where available. These solutions aim to provide clinicians with advanced capabilities for accuracy, flexibility, motion management, image guidance, adaptive workflows, and personalized treatment delivery. Accuray's solutions support clinical teams throughout individual treatments, across the treatment workflow, and during the entire patient treatment journey, from curative to palliative care. Across both its robotic and helical platforms, the solutions include radiation therapy systems with software-enabled motion management for real-time adaptation of treatment delivery for moving targets. They also offer treatment planning software that allows clinicians to utilize Accuray systems' capabilities to create high-quality treatment plans and support precise, efficient treatment delivery. ClearRT helical kVCT imaging technology, available on selected systems and configurations, produces high-quality CT images efficiently, with imaging length capabilities up to 135 cm on selected configurations, supporting broad anatomical visualization and adaptive treatment workflows. Automated tools help clinicians identify anatomical changes during treatment, evaluate the benefit of re-planning, and adapt radiation dose. Software tools also support efficient retreatment planning by evaluating prior dose information, generating new treatment plans, and assessing cumulative dose for patients who have previously received radiation therapy. The system architecture accommodates third-party surface guidance interfaces for patient positioning, monitoring positioning accuracy, and enabling deep inspiration breath hold ("DIBH") workflows for selected cancer treatments.

Accuray Incorporated (NASDAQ:ARAY) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 27 items for ARAY at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-11, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 15 rated 8 or above. Recent SEC coverage for ARAY spans 10-K, DEF 14A, 8-K, PRE 14A.

Recent high-impact activity:

  • Accuray Inks $8M RaySearch Deal to Accelerate Online Adaptive Radiation Therapy
  • Accuray 10-K: $49M Loss, Adverse ICFR Opinion, and Covenant Breach Confirmed
  • Accuray Sets October 6 Vote on $55M Recapitalization, Reverse Split, and 92% Dilution
  • Accuray Q4 Revenue Plunges 21%, FY26 Loss Widens to $49M
  • Accuray Q4 Revenue Falls 21%, Withdraws FY27 Guidance Amid Recapitalization

Financial Snapshot

Fiscal year ended June 30, 2026
Revenue
$401.95M
Net Income
-$49.19M
Op. Cash Flow
-$6.98M
Free Cash Flow
-$12.84M
Gross Profit
$111.45M
Operating Income
-$26.44M
Cash & Equivalents
$40.62M
Total Debt
$147.87M
Debt / Equity
3.55×
Net Margin
-12.2%
Shares Outstanding
119.43M sh
Source: 10-K · filed 2026-08-27 · accession 0001437749-26-029098

Dilution Risk

Low risk

Filing-implied dilution signals for ARAY, detected from its recent SEC filings · based on capital-structure filings through 2026-09-11.

1 recent capital raise1 shelf registration

Special Meeting Set for October 6 · 92% Dilution from Preferred Conversion

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with A →
$0.2501 -0.00% today
52-week range · as of 2026-08-27 $0.22 – $2.1
Market cap
$29.88M
Volume
698.4K (1.0× avg)
3-mo avg 698K
Live data · 2026-09-13 15:46 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ARAY - Latest Insights

ARAY
Sep 11, 2026, 9:55 AM EDT
Source: MFN by Modular Finance
Importance Score:
7
Price at Filing: $0.2558
Real-time Price: $0.2501 info
Change: -$0.0057 (-2%) info
Market Cap: $29.884M info
ARAY
Aug 27, 2026, 4:02 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $0.2621
Real-time Price: $0.2501 info
Change: -$0.012 (-5%) info
Market Cap: $29.884M info
ARAY
Aug 24, 2026, 4:02 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $0.2716
Real-time Price: $0.2501 info
Change: -$0.0215 (-8%) info
Market Cap: $29.884M info
ARAY
Aug 19, 2026, 4:05 PM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $0.3001
Real-time Price: $0.2501 info
Change: -$0.050 (-17%) info
Market Cap: $29.884M info
ARAY
Aug 19, 2026, 4:04 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.3157
Real-time Price: $0.2501 info
Change: -$0.0656 (-21%) info
Market Cap: $29.884M info
ARAY
Aug 12, 2026, 5:15 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $0.280
Real-time Price: $0.2501 info
Change: -$0.0299 (-11%) info
Market Cap: $29.884M info
ARAY
Jul 31, 2026, 7:00 AM EDT
Filing Type: S-3
Importance Score:
7
Price at Filing: $0.283
Real-time Price: $0.2501 info
Change: -$0.0329 (-12%) info
Market Cap: $29.884M info
ARAY
Jul 29, 2026, 6:26 PM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $0.2355
Real-time Price: $0.2501 info
Change: +$0.0146 (+6%) info
Market Cap: $29.884M info
ARAY
Jul 29, 2026, 5:25 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.2355
Real-time Price: $0.2501 info
Change: +$0.0146 (+6%) info
Market Cap: $29.884M info
ARAY
Jun 04, 2026, 4:02 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.3655
Real-time Price: $0.2501 info
Change: -$0.1154 (-32%) info
Market Cap: $29.884M info
ARAY
May 22, 2026, 3:57 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $0.3077
Real-time Price: $0.2501 info
Change: -$0.0576 (-19%) info
Market Cap: $29.884M info
ARAY
May 06, 2026, 4:09 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.4105
Real-time Price: $0.2501 info
Change: -$0.1604 (-39%) info
Market Cap: $29.884M info
ARAY
May 06, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.4724
Real-time Price: $0.2501 info
Change: -$0.2223 (-47%) info
Market Cap: $29.884M info
ARAY
Apr 28, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.4455
Real-time Price: $0.2501 info
Change: -$0.1954 (-44%) info
Market Cap: $29.884M info
ARAY
Apr 17, 2026, 6:03 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $0.425
Real-time Price: $0.2501 info
Change: -$0.1749 (-41%) info
Market Cap: $29.884M info
ARAY
Apr 07, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.4415
Real-time Price: $0.2501 info
Change: -$0.1914 (-43%) info
Market Cap: $29.884M info
ARAY
Apr 06, 2026, 9:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.4164
Real-time Price: $0.2501 info
Change: -$0.1663 (-40%) info
Market Cap: $29.884M info
ARAY
Mar 19, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.4305
Real-time Price: $0.2501 info
Change: -$0.1804 (-42%) info
Market Cap: $29.884M info
ARAY
Feb 27, 2026, 4:11 PM EST
Filing Type: 424B3
Importance Score:
7
Price at Filing: $0.5775
Real-time Price: $0.2501 info
Change: -$0.3274 (-57%) info
Market Cap: $29.884M info
ARAY
Feb 17, 2026, 4:19 PM EST
Filing Type: S-3
Importance Score:
8
Price at Filing: $0.5082
Real-time Price: $0.2501 info
Change: -$0.2581 (-51%) info
Market Cap: $29.884M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets